Hon CHRIS HIPKINS (Minister for COVID-19 Response): Mālō e lelei, Mr Speaker. I'm advised that to date a total of 34 letters of authorisation by the Director-General of Health have been issued under clause 9 of the COVID-19 Public Health Response (Point-of-care Tests) Order 2021, covering the import and supply of or use of rapid COVID-19 tests. Thirty-three of the authorisation letters related to rapid molecular tests that were already in use in laboratories in the national COVID-19 testing laboratory network prior to the order being issued, or to their use in laboratories that have operationalised our PCR tests since the order was issued. In relation to the second part of the member's question, the Ministry of Health is investigating options for the utilisation of rapid antigen tests in certain settings, such as for the healthcare workforce and as part of the point of arrivals trial within the reconnecting New Zealand work programme. One letter of authorisation has been issued to allow the Ministry of Health to import a quantity of rapid antigen tests so that the potential use of those tests under the public health response can be evaluated and/or piloted.